Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan European Discovery Trust Regulatory News (JEDT)

Share Price Information for JPMorgan European Discovery Trust (JEDT)

Share Price is delayed by 15 minutes
Get Live Data
649.00    2.00 (0.31%)
Bid:
648.00
Ask:
654.00
Spread: 6.00 (0.926%)
Market Cap: £591.57m
JEDT Live PriceLast checked at - London Stock Exchange

Intraday JPMorgan European Discovery Trust Share Chart

Closed Period Notification

1 Apr 2026 14:49

RNS Number : 1192Z
JPMorgan European Discovery Trust
01 April 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN EUROPEAN DISCOVERY TRUST PLC

(the 'Company')

 

Closed Period Notification

 

 

Legal Entity Identifier: 54930049CEWDI46Y3U28

 

Information disclosed in accordance with Market Abuse Regulation ('MAR') Article 19, paragraph 11

 

The Company announces that it is satisfied that all inside information (as defined under MAR) which the Directors and the Company may have in the period leading up to the announcement of its results for the year ended 31st March 2026 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore, the Company is not prohibited from dealing in its own securities.

 

The mandatory closed period under MAR will commence on 8th May 2026 and will last until the results in respect of the year ended 31st March 2026 are published, which is expected to be on or around 19th June 2026.

 

If in the period leading up to the announcement of the annual results the Directors of the Company come into the possession of any inside information, this will be notified to LSE without any delay and before any such transactions are undertaken.

 

 

 

1st April 2026

 

 

JPMorgan Funds Limited - Company Secretary

 

 

For further information, please contact:

 

Sachu Saji

JPMorgan Funds Limited

0800 20 40 20 (or +44 1268 44 44 70)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBXGDSRSGDGLB
Date   Source Headline
23rd Dec 202411:18 amRNSGearing announcement
23rd Dec 202410:41 amRNSNet Asset Value(s)
20th Dec 202411:42 amRNSNet Asset Value(s)
19th Dec 20245:07 pmRNSTransaction in Own Shares
19th Dec 202410:43 amRNSNet Asset Value(s)
18th Dec 20245:16 pmRNSTransaction in Own Shares
18th Dec 202410:48 amRNSNet Asset Value(s)
18th Dec 202410:19 amRNSHolding(s) in Company
17th Dec 20246:06 pmRNSTransaction in Own Shares (Replacement)
17th Dec 20245:58 pmRNSTransaction in Own Shares
17th Dec 20245:19 pmRNSHolding(s) in Company
17th Dec 20245:13 pmRNSTransaction in Own Shares
17th Dec 202410:57 amRNSNet Asset Value(s)
16th Dec 20243:45 pmRNSHolding(s) in Company
16th Dec 202411:35 amRNSGearing announcement
16th Dec 202410:57 amRNSNet Asset Value(s)
13th Dec 20245:12 pmRNSTransaction in Own Shares
13th Dec 202410:51 amRNSNet Asset Value(s)
12th Dec 20245:42 pmRNSTransaction in Own Shares
12th Dec 202410:21 amRNSNet Asset Value(s)
11th Dec 20244:57 pmRNSTransaction in Own Shares
11th Dec 20243:21 pmRNSTen Largest Investments
11th Dec 202411:10 amRNSNet Asset Value(s)
10th Dec 20245:04 pmRNSTransaction in Own Shares
10th Dec 202410:43 amRNSNet Asset Value(s)
9th Dec 20245:20 pmRNSTransaction in Own Shares
9th Dec 202412:17 pmRNSGearing Announcement
9th Dec 202410:43 amRNSNet Asset Value(s)
9th Dec 20247:05 amRNSDividend Declaration
9th Dec 20247:00 amRNSHalf-year Report
6th Dec 20245:17 pmRNSTransaction in Own Shares
6th Dec 202411:25 amRNSNet Asset Value(s)
5th Dec 20245:17 pmRNSTransaction in Own Shares
5th Dec 202410:26 amRNSNet Asset Value(s)
4th Dec 20245:16 pmRNSTransaction in Own Shares
4th Dec 202410:33 amRNSNet Asset Value(s)
3rd Dec 20245:27 pmRNSTransaction in Own Shares
3rd Dec 202410:45 amRNSNet Asset Value(s)
2nd Dec 20245:18 pmRNSTransaction in Own Shares
2nd Dec 20241:19 pmRNSGearing announcement
2nd Dec 202412:16 pmRNSNet Asset Value(s)
2nd Dec 202410:58 amRNSTotal Voting Rights
29th Nov 20245:09 pmRNSTransaction in Own Shares
29th Nov 202410:55 amRNSNet Asset Value(s)
28th Nov 20245:38 pmRNSTransaction in Own Shares
28th Nov 202411:56 amRNSNet Asset Value(s)
27th Nov 20245:15 pmRNSTransaction in Own Shares
27th Nov 20245:01 pmRNSHolding(s) in Company
27th Nov 202411:19 amRNSNet Asset Value(s)
26th Nov 20245:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.